enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Benzbromarone - Wikipedia

    en.wikipedia.org/wiki/Benzbromarone

    Benzbromarone is a uricosuric agent and non-competitive inhibitor of xanthine oxidase [1] used in the treatment of gout, especially when allopurinol, a first-line treatment, fails or produces intolerable adverse effects.

  3. What Does a Mixed FDA Verdict Mean for Sanofi's MS Drug? - AOL

    www.aol.com/news/2013-11-16-what-does-a-mixed...

    An FDA advisory panel recently recommended the approval of Sanofi's multiple sclerosis drug, Lemtrada. However, that approval came among some mixed and contradictory opinions about the drug and ...

  4. Sanofi - Wikipedia

    en.wikipedia.org/wiki/Sanofi

    Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers ...

  5. Roussel Uclaf - Wikipedia

    en.wikipedia.org/wiki/Roussel_Uclaf

    Roussel Uclaf S.A. was a French pharmaceutical company and one of several predecessor companies of today's Sanofi. It was the second largest French pharmaceutical company [6] before it was acquired by Hoechst AG of Frankfurt, Germany in 1997, with pharmaceutical operations combined into the Hoechst Marion Roussel (HMR) division in the United States.

  6. Sanofi's GLP-1 Accepted for Review by FDA - AOL

    www.aol.com/news/2013-02-20-sanofis-glp-1...

    Sanofi announced this week that the Food and Drug Administration began to review the company's once-daily type 2 diabetes injectable lixisenatide. The GLP-1 agonist would join a crowded market led ...

  7. Apotex Inc v Sanofi-Synthelabo Canada Inc - Wikipedia

    en.wikipedia.org/wiki/Apotex_Inc_v_Sanofi...

    Apotex Inc v Sanofi-Synthelabo Canada Inc, [2008] 3 S.C.R. 265, is a leading Supreme Court of Canada decision on the novelty and non-obviousness requirements for a patent in Canada. The Court rejected a challenge by the generic drug manufacturer Apotex to declare Synthelabo Canada 's patent for Plavix , an anti-coagulant drug, invalid.

  8. Hoechst AG - Wikipedia

    en.wikipedia.org/wiki/Hoechst_AG

    The former Hoechst AG and today's Industriepark Höchst. Hoechst AG (German pronunciation: [ˈhøːçst]) was a German chemicals, later life sciences, company that became Aventis Deutschland after its merger with France's Rhône-Poulenc S.A. in 1999.

  9. SL651498 - Wikipedia

    en.wikipedia.org/wiki/SL651498

    SL651498 is an anxiolytic and anticonvulsant drug used in scientific research, with a chemical structure most closely related to β-carboline derivatives such as abecarnil and gedocarnil. [1]